Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

Journal:

Journal of Infectious Diseases

Published:

2025-10-30

DOI:

10.1093/infdis/jiaf504

Affiliations:

15

Authors:

18

Go to article

Institutions	Authors	Share
Harvard University, United States of America (USA)	3.000000	0.17
Stellenbosch University (SU), South Africa	2.000000	0.11
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.000000	0.06
University of the Witwatersrand, Johannesburg (Wits University), South Africa	1.000000	0.06
Kilimanjaro Christian Medical Centre (KCMC), Tanzania	1.000000	0.06
University of Southern California (USC), United States of America (USA)	1.000000	0.06
Department of Pediatrics, UC San Diego, United States of America (USA)	1.000000	0.06
Boston University (BU), United States of America (USA)	1.000000	0.06
University of Cape Town (UCT), South Africa	1.000000	0.06
FHI 360, United States of America (USA)	1.000000	0.06
Frontier Science Foundation, United States of America (USA)	1.000000	0.06
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	1.000000	0.06
NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), United States of America (USA)	1.000000	0.06
Tygerberg Hospital, SU, South Africa	1.000000	0.06
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.06

Interested in Pharmacology and Pharmaceutical Sciences?